Showing results (111-120 of 128) with videos related to
Sort By:
Pageof 13
Science (New York, N.Y.)|June 7, 2003
Laboratory simulation of charge exchange-produced X-ray emission from cometsP Beiersdorfer, K R Boyce, G V Brown, et al.Journal of Medicinal Chemistry|January 3, 1997
Discovery of potent isoxazoline glycoprotein IIb/IIIa receptor antagonistsJ Wityak, T M Sielecki, D J Pinto, et al.Coronary Artery Disease|October 1, 1996
Novel nonpeptide antiplatelet glycoprotein IIb/IIIa receptor antagonist, DMP754: receptor binding affinity and specificityS A Mousa, M Forsythe, W Lorelli, et al.The Review of Scientific Instruments|December 3, 2008
Design of a streaked radiography instrument for ICF ablator tuning measurementsR E Olson, D G Hicks, B K Spears, et al.Journal of Cardiovascular Pharmacology|August 13, 1998
Oral antiplatelet efficacy and specificity of a novel nonpeptide platelet GPIIb/IIIa receptor antagonist, DMP 802S A Mousa, R E Olson, J M Bozarth, et al.Nature Communications|January 30, 2020
Observation of persistent species temperature separation in inertial confinement fusion mixturesBrian M Haines, R C Shah, J M Smidt, et al.The Journal of Biological Chemistry|August 1, 2000
Presenilin-1 and -2 are molecular targets for gamma-secretase inhibitorsD Seiffert, J D Bradley, C M Rominger, et al.Journal of Medicinal Chemistry|April 10, 1999
Orally active isoxazoline glycoprotein IIb/IIIa antagonists with extended duration of actionR E Olson, T M Sielecki, J Wityak, et al.Journal of Medicinal Chemistry|June 20, 1997
Discovery of an orally active series of isoxazoline glycoprotein IIb/IIIa antagonistsC B Xue, J Wityak, T M Sielecki, et al.Bioorganic & Medicinal Chemistry Letters|January 5, 1999
MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization productsJ V Duncia, J B Santella, C A Higley, et al.Pageof 13